AVITA Medical, Inc. (NASDAQ:RCEL) Q2 2022 Results Conference Call August 11, 2022 5:00 PM ET

Company Participants

Caroline Corner - Managing Director, Investor Relations

Dr. Mike Perry - Chief Executive Officer

Michael Holder - Chief Financial Officer

Conference Call Participants

Josh Jennings - Cowen

Ryan Zimmerman - BTIG

Operator

Hello. Thank you for standing by and welcome to the AVITA Medical Inc. Second Quarter 2022 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference maybe recorded.

I would now like to hand the conference over to your speaker today, Caroline Corner. Please go ahead.

Caroline Corner

Thank you, operator. Welcome to AVITA Medical's second quarter 2022 earnings call. Joining me on today's call are Dr. Mike Perry, Chief Executive Officer; and Michael Holder, Chief Financial Officer.

This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical facts should be considered forward-looking statements, including statements regarding the markets in which AVITA Medical operates, trends, demand, and expectations for its products and technology, its expected financial performance, expenses, and position in the market, and the impact of COVID-19 on its operations and its customer's operations.

These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results, performance, or achievements to differ materially from any results performance or achievements expressed or implied by the forward-looking statements.

Please review AVITA Medical's most recent filings with the SEC, particularly the risk factors described in AVITA Medical's S3 and 10-K filings, and in AVITA Medical's quarterly report on Form 10-Q for the first quarter ended June 30, 2022, for additional information. Any forward-looking statements provided during this call, including projections for future performance, are based on management's expectations as of today. AVITA Medical undertakes no obligation to update these statements except as required by applicable law.

AVITA Medical's press release with the second quarter 2022 results is available on its website, www.avitamedical.com under the Investors section and includes additional details about its financial results. AVITA Medical's website also has the latest SEC filings which you are encouraged to review. A recording of today's call will be available on AVITA Medical's website by 05:00 PM Pacific Time today.